Effects of warfarin and L-carnitine on hemostatic function and oxidative stress in streptozotocin-induced diabetic rats

Journal of Physiology and Biochemistry

Volumn 70, Issue 2, 2014, Pages 535-546

  ElGendy, Ahmed A ^a   Abbas, Amr M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Coagulation; Diabetes mellitus; L Carnitine; Oxidative stress; Warfarin

Indexed keywords

ANTIOXIDANT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; CARNITINE; CATALASE; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A1C; INSULIN; MALONALDEHYDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; SUPEROXIDE DISMUTASE; WARFARIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; DRUG EFFECT; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HYPERCOAGULABILITY; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; THROMBOCYTE AGGREGATION; ANIMAL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CARNITINE; DIABETES MELLITUS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; WARFARIN;

EID: 84904677293     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-014-0333-4     Document Type: Article

References (46)

1. Abou-Seif MA, Youssef AA (2004) Evaluation of some biochemical changes in diabetic patients. Clin Chem Acta 346:161-170 (Pubitemid 38901047)
2. Acang N, Jalil FD (1993) Hypercoagulation in diabetes mellitus. Southeast Asian J Trop Med Public Health 24:263-266
3. Ansell J, Hirsh J, Hylek E et al (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 133(6 Suppl):160S-198S (Pubitemid 351892967)
4. Asakawa H, Tokunaga K, Kawakami F (2000) Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabet Complicat 14:121-126
5. Brownlee M, Vlassara H, Cerami A (1983) Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin. Diabetes 32:600-604
6. Ceriello A, Giugliano D, Quatraro A et al (1987) Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes 36:320-323 (Pubitemid 18028423)
7. Chan P, Pan WH (1995) Coagulation activation in type 2 diabetes mellitus: the higher coronary risk of female diabetic patients. Diabet Med 12:504-507
8. Choonara IA, Malia RG, Haynes BP et al (1988) The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activitywith warfarin. Br J Clin Pharmacol 25:1-7
9. Clozel M, Hess P, Qiu C, Ding SS, Rey M (2006) The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats. J Pharmacol Exp Ther 316:1115-1121 (Pubitemid 43345285)
10. Derin N, Izgut-Uysal VN, Agac A, Aliciguzel Y, Demir N (2004) L-carnitine protects gastric mucosa by decreasing ischemia reperfusion induced lipid peroxidation. J Physiol Pharmacol 55:595-606 (Pubitemid 39318851)
11. Derosa G, Maffioli P, Ferrari I, D'Angelo A, Fogari E, Palumbo I, Randazzo S, Cicero AFG (2010) Orlistat and Lcarnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocr J 57(9):777-786
12. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407 (Pubitemid 19250701)
13. Gonzalez E, Rosello-Catafau J, Jawerbaum A, Sinner D, Pustovrh C, Vela J et al (2000) Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocininduced diabetes mellitus in the rat. Braz J Med Biol Res 33:1335-1342
14. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165(10):1095-1106 (Pubitemid 40720733)
15. Jay D, Hitomi H, Griendling KK (2006) Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40:183-192 (Pubitemid 43069343)
16. Kolodziejczyk J, Saluk-Juszczak J, Wachowicz B (2011) Lcarnitine protects plasma components against oxidative alterations. Nutrition 27:693-699
17. Komurcu E, Ozkan OF, Kemik AS, Nusran G, Asik M, Arslan E (2013) Effect of systemic carnitine therapy on serum fibronectin level in diabetic rats. J Surg Res xxx:1-6 (Article in Press)
18. Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007:Article ID 43603
19. Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB (2005) Reactive oxygen speciesmediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int 67:1762-1771 (Pubitemid 40577711)
20. Lemini C, Rubio-Póo C, Silva G, Garcia-Mondragon J, Zavala E, Mendoza-Patiño N, Castro D, Cruz-Almanza R, Mandoki JJ (1993) Anticoagulant and estrogenic effects of two new 17β-aminoestrogens, butolame [17β-(4-hydroxy-1- butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17β-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol]. Steroids 58:457-461
21. Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB (2010) Hyperglycemia: a prothrombotic factor? J Thromb Haemost 8:1663-1669
22. Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW (2004) Identification of the gene for vitamin K epoxide reductase. Nature 427(6974):541-544 (Pubitemid 38209111)
23. Liepinsh E, Skapare E, Vavers E, Konrade I, Strele I, Grinberga S, Pugovics O, Dambrova M (2012) High Lcarnitine concentrations do not prevent late diabetic complications in type 1 and 2 diabetic patients. Nutrition research 32:320-327
24. Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M (2009) L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr 89:71-76
25. Michno A, Raszeja-Specht A, Jankowska-Kulawy A, Pawelczyk T, Szutowicz A (2005) Effect of L-carnitine on acetyl-CoA content and activity of blood platelets in healthy and diabetic persons. Clin Chem 51:1673-1682 (Pubitemid 41233103)
26. Morel O, Kessler L, Ohlmann P, Bareiss P (2010) Diabetes and the platelet: toward new therapeutic paradigms for diabetic atherothrombosis. Atherosclerosis 212(2):367-376
27. Mustard JF, Hegard TB, RowSell HC (1964) Effects of adenosine nucleotides on platelet aggregation and clotting time. J Lab Clin Med 64:548
28. Ng VL (2009) Prothrombine time and partial thromboplastin time assay considerations. Clin Lab Med 29:253-263
29. Nwose EU, Jelinek HF, Richards RS, Tinley P, Kerr PG (2009) Atherothrombosis and oxidative stress: the connection and correlation in diabetes. Redox Rep 14:55-60
30. Oberley LW (1988) Free radicals and diabetes. Free Radic Biol Med 5:113-124
31. Pignatelli P, Lenti L, Sanguigni V, Frati G, Simeoni I, Gazzaniga PP et al (2003) Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress. Am J Physiol Heart Circ Physiol 284:41-48
32. Rani PJA, Panneerselvam C (2001) Carnitine as a free radical scavenger in aging. Exp Gerontol 36:1713-1726
33. Reddi AS, Jyothirmayi GN, DeAngelis B, Frank O, Baker H (1991) Effect of short- and long-term diabetes on carnitine and myo-inositol in rats. Comp Biochem Physiol A Physiol 98:39-42
34. Ringseis R, Keller J, Eder K (2012) Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr 51:1-18
35. Saluk-Juszczak J, Olas B, Wachowicz B, Glowacki R, Bald E (2010) L-carnitine modulates blood platelet oxidative stress. Cell Biol Toxicol 26:355-365
36. Schneider R, Löster H, Aust W, Craatz S, Welt K, Fitzl G (2005) Protective effects of L-carnitine on myocardium of experimentally diabetic rats with additional ischaemia and reperfusion. Monatsh Chem 136:1467-1481 (Pubitemid 41095372)
37. Soneru IL, Khan T, Orfalian Z, Abraira C (1997) Acetyl-Lcarnitine effects on nerve conduction and glycemic regulation in experimental diabetes. Endocr Res 23:27-36 (Pubitemid 27272708)
38. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diab Care 16:434-444 (Pubitemid 23046633)
39. Stegenga M, van der Crabben S, Levi M et al (2006) Hyperglycemia stimulates coagulation, whereas hyperinsulinaemia impairs fibrinolysis in healthy individuals. Diabetes 55:1807-1812 (Pubitemid 44324136)
40. Tikoo K, Tripathi DN, Kabra DG, Sharma V, Gaikwad AB (2007) Intermittent fasting prevents the progression of type I diabetic nephropathy in rats and changes the expression of Sir2 and p53. FEBS Lett 581(5):1071-1078 (Pubitemid 46282743)
41. Uysal N, Yalaz G, Acikgoz O, Gonenc S, Kayatekin BM (2005) Effect of L-carnitine on diabetogenic action of streptozotocin in rats. Neuro Endocrinol Lett 26(4):419-422 (Pubitemid 41518788)
42. Vidal-Casariego A, Burgos-Peláez R, Martínez-Faedo C, Calvo-Gracia F, Valero-Zanuy MÁ, Luengo-Pérez LM, Cuerda-Compés C (2013) Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and metaanalysis. Exp Clin Endocrinol Diabetes 121:234-238
43. Villanueva GB, Allen N (1988) Demonstration of altered anti thrombin III activity due to non enzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients. Diabetes 37:1103-1107 (Pubitemid 19033593)
44. Wolff SP, Jiang ZY, Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10:339-352 (Pubitemid 121003905)
45. Yanagita M, Arai H, Ishii K, Nakano T, Ohashi K, Mizuno K, Varnum B, Fukatsu A, Doi T, Kita T (2001) Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol 158:1423- 1432
46. Zangiabadi N, Sheibani V, Asadi-Shekaari M, Shabani M, Jafari M, Asadi AR, Tajadini H, Jarahi M (2011) Effects of melatonin in prevention of neuropathy in STZ-induced diabetic rats. Am J Pharmacol Toxicol 6(2):59-67